Acasă › Supraponderalitate › North Carolina

Studii clinice pentru Supraponderalitate în North Carolina

40 studii pentru Supraponderalitate caută participanți în North Carolina.

Orașe în North Carolina

Text oficial al studiului (în engleză)

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Medication Management /ID# 281965, Greensboro
Monroe Biomedical Research /ID# 282009, Monroe
Centricity Research - Morehead city /ID# 283264, Morehead City
și încă 2

În curs de recrutareFaza 2

Vârste de la 18 la 75 · Toate sexele · Actualizat 2 oct. 2026 · NCT07752979

FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)

University of North Carolina at Chapel Hill, Chapel Hill

În curs de recrutare

Vârste de la 18 la 75 · Toate sexele · Actualizat 29 sept. 2026 · NCT06724406

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

TMA Headlands, Wilmington

În curs de recrutareFaza 2

Vârste de la 18 la 75 · Toate sexele · Actualizat 28 sept. 2026 · NCT07837973

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Medication Mgmnt, LLC_Grnsboro, Greensboro
Accellacare of Raleigh, Raleigh
Accellacare-Salisbury PMG Res, Salisbury
și încă 1

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 28 sept. 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

PharmQuest Life Sciences LLC, Greensboro
Piedmont Healthcare/Research, Statesville

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 28 sept. 2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Medication Management, Greensboro
Monroe Biomedical Research, Monroe
West Clinical Research, Morehead City
și încă 1

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 28 sept. 2026 · NCT07794579

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Medication Management, LLC, Greensboro
Accellacare - Wilmington, Wilmington
Jeffrey Coleman, OD, Wilmington

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 28 sept. 2026 · NCT07595549

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Research Site, Statesville

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT07776509

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Coastal Research Institute - Fayetteville, Fayetteville

În curs de recrutareFaza 3

Vârste de la 18 la 70 · Toate sexele · Actualizat 24 sept. 2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

UNC Children's Hospital, Chapel Hill
Duke Children's Primary Care, Durham
Lucas Research, Inc, Morehead City

În curs de recrutareFaza 3

Vârste de la 6 la 17 · Toate sexele · Actualizat 24 sept. 2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Coastal Research Institute - Fayetteville, Fayetteville

În curs de recrutareFaza 3

Vârste de la 18 la 70 · Toate sexele · Actualizat 24 sept. 2026 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

PharmQuest Life Sciences, LLC, Greensboro
West Clinical Research, Morehead City
Trial Management Associates - Wilmington - Floral Parkway, Wilmington

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

University of North Carolina Medical Center, Chapel Hill
Medication Management, Greensboro
Carteret Medical Group, Morehead City
și încă 1

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Research Site, Monroe

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Novant Health Heart and Vascular Institute, Charlotte
Velocity Clinical Research - Durham, Durham
Moses H Cone Memorial Hospital, Greensboro
și încă 7

În curs de recrutareFaza 3

Vârste de la 45 la 99 · Toate sexele · Actualizat 22 sept. 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Monroe Biomedical Research, Monroe

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07321886

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Medication Management, Greensboro
Monroe Biomedical Research, Monroe
Lucas Research, Inc, Morehead City
și încă 1

În curs de recrutareFaza 2

Vârste de la 18 la 75 · Toate sexele · Actualizat 22 sept. 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

AURORA-1 Clinical Site, Charlotte
AURORA-1 Clinical Site, Greenville
AURORA-1 Clinical Site, Morehead City
și încă 1

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 16 sept. 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Charlotte
AURORA-2 Clinical Site, Durham
AURORA-2 Clinical Site, Greenville
și încă 2

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 16 sept. 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Centricity Research Morehead City Multispeciality, Morehead City
Wake Forest University Health Sciences, Winston-Salem

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 14 sept. 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Lucas Research, Inc., Morehead City
Shelby Clinical Research, Shelby

În curs de recrutareFaza 2

Vârste de la 18 la 75 · Toate sexele · Actualizat 14 sept. 2026 · NCT06897475

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

ACCOMPLISH-2 Research Site, Charlotte
ACCOMPLISH-2 Research Site, Durham
ACCOMPLISH-2 Research Site, Fayetteville
și încă 2

În curs de recrutareFaza 3Voluntari sănătoși bineveniți

Vârste de la 18 la 79 · Toate sexele · Actualizat 11 sept. 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Medication Management, Greensboro
Monroe Biomedical Research, Monroe
Lucas Research, Inc, Morehead City
și încă 1

În curs de recrutareFaza 2

Vârste de la 18 la 75 · Toate sexele · Actualizat 8 sept. 2026 · NCT06143956

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Revival Research Institute, LLC, Cary
Onsite Clinical Solutions - Huntersville, Huntersville

În curs de recrutareFaza 4

Vârste de 18 ani și peste · Toate sexele · Actualizat 4 sept. 2026 · NCT06857942

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

PharmQuest, Greensboro
KDCILM, LLC & Accellacare US, Inc., Wilmington

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 4 sept. 2026 · NCT07745504

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Kailera Clinical Site, Greensboro
Kailera Clinical Site, Monroe
Kailera Clinical Site, Morehead City
și încă 1

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 3 sept. 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Accellacare of Hickory, Hickory
Carolina Research Center Inc, Shelby

În curs de recrutareFaza 3

Vârste de la 18 la 99 · Toate sexele · Actualizat 3 sept. 2026 · NCT07684235

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Kailera Clinical Site, Morehead City

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 3 sept. 2026 · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

West Clinical Research, Morehead City

În curs de recrutareFaza 3

Vârste de la 18 la 99 · Toate sexele · Actualizat 3 sept. 2026 · NCT07684144

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Centricity Research Morehead City Specialty, Morehead City
Accellacare of Raleigh, Raleigh
Accellacare Research of Wilmington, Wilmington

În curs de recrutareFaza 3

Vârste de la 18 la 99 · Toate sexele · Actualizat 27 aug. 2026 · NCT07575399

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Research Site, Statesville

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 25 aug. 2026 · NCT07784725

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Piedmont Healthcare/Research, Statesville

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 17 aug. 2026 · NCT07509307

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

ACCOMPLISH-1 Research Site, Charlotte
ACCOMPLISH-1 Research Site, Durham
ACCOMPLISH-1 Research Site, Fayetteville
și încă 3

În curs de recrutareFaza 3

Vârste de la 18 la 79 · Toate sexele · Actualizat 10 aug. 2026 · NCT07654361

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

Monroe Biomedical Research, LLC, Monroe
Accellacare, Wilmington

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 25 iun. 2026 · NCT07607587

A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.

Monroe Biomedical Research, Monroe

În curs de recrutareFaza 2

Vârste de la 18 la 60 · Toate sexele · Actualizat 22 iun. 2026 · NCT07570758

Pregnancy Exercise Mode Effect on Childhood Obesity

East Carolina University, Greenville

În curs de recrutareVoluntari sănătoși bineveniți

Vârste de la 18 la 45 · Femei · Actualizat 4 iun. 2026 · NCT04805502

NDPP-NextGen: A Clinical Trial to Reduce Intergenerational Obesity and Diabetes Risks

Wake Forest University Health Sciences, Winston-Salem

În curs de recrutareVoluntari sănătoși bineveniți

Vârste de la 18 la 39 · Femei · Actualizat 27 feb. 2026 · NCT05674799

A Mobile Intervention to Reduce Pain and Improve Health-III

Wake Forest University, Winston-Salem

În curs de recrutareFaza 2

Vârste de 65 ani și peste · Toate sexele · Actualizat 20 feb. 2026 · NCT06623669

MAINTAIN (Mucosal AblatIoN Therapy After INcretins)

True You Weight Loss, Cary
True You Weight Loss, Cary

În curs de recrutare

Vârste de la 21 la 65 · Toate sexele · Actualizat 21 mar. 2025 · NCT06734312

REvision of VSG with Ablation of the Mucosa Procedure

True You Weight Loss, Cary

În curs de recrutare

Vârste de la 22 la 60 · Toate sexele · Actualizat 5 nov. 2024 · NCT06671119

Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.